-
She does make some very good points here with bringing in additional revenue to allow the FDA to inspect more over seas manufacturing facilities. She also states that branded companies as well as generic drug companies both need need more attention with inspections. Currently in the US factories...
-
Sales have fallen and I guess even that big reward from Boston Scientific for 2 billion in 2010 was not enough to keep things rolling along here. Apparently the stent business is growing in other places and sales are down to 2.5 billion from 4 billion just a few years ago. Other companies...
Posted to
The Medical Quack .... by Barbara Duck
by
The Medical Quack
on
Thu, Feb 10 2011
Filed under:
Filed under: Medically Related, Technology, drugs, healthcare, Medical Devices, Pharma, Biotech, FDA, Stents, Recalls, Legal Suits, Investments, Boston Scientific, Johnson and Johson, Cordis
-
If you have been a reader here long enough at the Quack then you have probably read one of my articles about the use of bar codes on drugs and medical devices. We have somewhat of a step in this direction, but lots of lack luster still missing. You can read the short paragraph below and see...
Posted to
The Medical Quack .... by Barbara Duck
by
The Medical Quack
on
Mon, Feb 7 2011
Filed under:
Filed under: Medically Related, Technology, Pharma/FDA News, drugs, Tracking, Pharma, FDA, cell phones, Safety, information, Scanning, Bar Codes, MDs, adverising, FadeMark
-
This is a game or situation that Johnson and Johnson seems to be good at with their multitude of legal cases with stents. This time they are on the losing end of the stick with a jury ruling they violated a patent. The same researcher also won a case against Boston Scientific on his design...
Posted to
The Medical Quack .... by Barbara Duck
by
The Medical Quack
on
Sat, Jan 29 2011
Filed under:
Filed under: Medically Related, Pharma/FDA News, drugs, healthcare, Medical Devices, Pharma, Biotech, FDA, Stents, Recalls, Legal Suits, Investments, Boston Scientific, Johnson and Johson
-
It doesn’t get much more upfront than this with one mentioning their feelings on how the company is being run does it. The one quote below is interesting too in the fact that “everything is under control”? How come we have more recalls coming up all the time? As soon as one fire is...
Posted to
The Medical Quack .... by Barbara Duck
by
The Medical Quack
on
Thu, Jan 27 2011
Filed under:
Filed under: Medically Related, Pharma/FDA News, Other Items of Interest, healthcare, Investors, Pharma, FDA, Johnson and Johnson, Recalls, Wall Street, McNeil Consumer Healthcare, Bill Weldeon
-
The cuts amount to around 2% of the workforce. The company has also had their share of recalls and the glucose strips were huge and again states the need for a way of consumers, doctors and pharmacists to identify them. Abbott Diabetes Care Recalls Tons of Glucose Test Strips–The US Has the...
Posted to
The Medical Quack .... by Barbara Duck
by
The Medical Quack
on
Thu, Jan 27 2011
Filed under:
Filed under: Medically Related, Pharma/FDA News, Pharma, FDA, Abbott, weight loss, obesity, Recalls, Drug Safety, women's health, Beauty, jobs, Food Safety and Recalls
-
Well the patients in the US have to wait a little longer and it is amazing that in Europe as the title suggests has generics available. In May of 2010 Plavix was given a ruling by the FDA to establish a black box warning too. FDA Gives Plavix New Box Warning Relating to Metabolization in...
Posted to
The Medical Quack .... by Barbara Duck
by
The Medical Quack
on
Wed, Jan 26 2011
Filed under:
Filed under: Medically Related, Pharma/FDA News, Pharma, Pills, FDA, Generic Drugs, Marketing, Patents, Europe, Plavix, Sanofi-Aventis, expire, Bristol-Myers Squibb
-
Vilazodone is a modulator of serotonin neurotransmission to be used for treatment of Major Depression Disorders. Now there’s one more choice for depression, it’s amazing if you look how many of these are out there. BD From the website: “Nearly 2,900 patients have been exposed to vilazodone...
-
REMS programs are required by the FDA for certain marketed drugs to ensure the benefits of a product offered to consumers outweigh the risks . They can include elements to ensure safe use, communications plans and medication guides, which all require assessment. Just a few months ago, another REMS...
Posted to
The Medical Quack .... by Barbara Duck
by
The Medical Quack
on
Mon, Jan 10 2011
Filed under:
Filed under: Medically Related, Pharma/FDA News, Pharma, Cancer, FDA, Pain Relief, REMS, risk evalaution and mitigation strategy, addictive drugs, ProStraken), Abstral, register
-
This article makes one statement for sure is that someone is ready to gamble on just about anything. This kind of dilutes the seriousness of the situation when investors basically are sitting back and bet on the outcome of litigation. So now it appears bets outside of the normal areas of...
-
When we hear news of such, it’s reminds us of outsourcing thoughts too. As the article states this is the second blast/fire this month as another such incident 2 weeks ago also killed 5 people. I didn’t find any references to whether or not they manufacture for any US drug companies, which...
Posted to
The Medical Quack .... by Barbara Duck
by
The Medical Quack
on
Fri, Dec 31 2010
Filed under:
Filed under: Medically Related, Pharma/FDA News, Pharma, Pills, FDA, Heatlhcare, China, Safety, Medications, exports, deaths, imports, Quanxin
-
It’s just about one year now since I started this campaign with using Bar Codes, Microsoft Tags and I’m up to around 60 posts on the topic now, and just about every time there’s a recall, I do another post. Look how retailers and consumers are using this technology but when it comes to something...
Posted to
The Medical Quack .... by Barbara Duck
by
The Medical Quack
on
Thu, Dec 23 2010
Filed under:
Filed under: Medically Related, Technology, Pharma/FDA News, drugs, microsoft, Medical Devices, Pharma, FDA, Twitter, cell phones, Recalls, Scanning, Abbot Labs, MicrosoftTags, luddites
-
There were a large number rejected but there was also a large number that slipped through. Now when it comes to Medicare Part D, as we all know by now this is administered by insurance companies and their data so in essence, this is due to the lack of full data by those administering the plans and updating...
Posted to
The Medical Quack .... by Barbara Duck
by
The Medical Quack
on
Thu, Nov 11 2010
Filed under:
Filed under: Medically Related, Other Items of Interest, drugs, Pharma, FDA, Medicare Part D, CMS, Data, Algorithms, less than effective drugs
-
Belatacept is an important new drug to help in the rejection process with organ transplants. The drug is actually made in New York but packaged in Puerto Rico. If you have ever been to Puerto Rico, there are many drug factories that have been there for years, it’s like pharma manufacturing...
Posted to
The Medical Quack .... by Barbara Duck
by
The Medical Quack
on
Sat, Oct 30 2010
Filed under:
Filed under: Medically Related, Pharma/FDA News, drugs, healthcare, Pharma, FDA, Organ transplants, Puerto Rico, Bristol Myers Squibb, Belatacept
-
Here’s one more warning on quality for the Chinese pharmaceutical manufacturers with more than the allowed levels found in a very common ingredient used with drug and dietary supplements. The FDA states it doesn’t see this as having any health issues up front; however, if used in this current form...
Posted to
The Medical Quack .... by Barbara Duck
by
The Medical Quack
on
Sat, Oct 23 2010
Filed under:
Filed under: Medically Related, Pharma/FDA News, drugs, Pharma, FDA, China, alerts, Tianjin Boai, peroxide, imports